Hanneke Schuitemaker Selected Research

GP 140

5/2022	Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.
1/2018	Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
7/2012	Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
7/2011	Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanneke Schuitemaker Research Topics

Disease

63	Infections 01/2022 - 01/2002
26	Disease Progression 11/2014 - 01/2002
17	COVID-19 04/2022 - 10/2020
16	Acquired Immunodeficiency Syndrome (AIDS) 07/2016 - 02/2003
15	HIV Infections (HIV Infection) 01/2020 - 05/2003
6	Vaccinia 05/2022 - 04/2016
4	Virus Diseases (Viral Diseases) 11/2020 - 12/2010
3	Weight Loss (Weight Reduction) 01/2022 - 11/2020
3	Viremia 01/2018 - 03/2002
2	Pneumonia (Pneumonitis) 03/2021 - 11/2020
2	Myalgia 01/2021 - 01/2020
2	Human Influenza (Influenza) 01/2021 - 01/2018
2	Pain (Aches) 01/2021 - 01/2020
2	Fatigue 01/2021 - 01/2020
2	Respiratory Syncytial Virus Infections 01/2020 - 10/2015
2	Poliomyelitis (Polio) 11/2018 - 01/2013
2	Persistent Infection 01/2017 - 01/2013
2	Superinfection 10/2016 - 12/2008
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2021
1	Common Cold 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Headache (Headaches) 01/2021
1	Severe Acute Respiratory Syndrome 11/2020
1	Coronavirus Infections 11/2020
1	Chills 01/2020
1	Dizziness (Lightheadedness) 01/2018
1	Back Pain (Backache) 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	HIV Seropositivity 10/2014
1	Hypercholesterolemia 07/2013
1	Hypertension (High Blood Pressure) 07/2013
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2012
1	Dementia (Dementias) 01/2012
1	Inflammation (Inflammations) 09/2010

Drug/Important Bio-Agent (IBA)

38	VaccinesIBA 05/2022 - 04/2010
13	RNA (Ribonucleic Acid)IBA 10/2014 - 12/2002
12	Ad26COVS1IBA 04/2022 - 01/2021
11	Neutralizing AntibodiesIBA 04/2022 - 04/2010
10	AntigensIBA 03/2021 - 08/2005
9	AntibodiesIBA 01/2022 - 08/2009
8	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2010
8	Broadly Neutralizing AntibodiesIBA 01/2019 - 01/2007
8	EpitopesIBA 07/2012 - 12/2003
4	GP 140IBA 05/2022 - 07/2011
4	Viral RNAIBA 03/2016 - 10/2007
4	HLA-B57 antigenIBA 11/2014 - 09/2007
4	Amino Acids FDA Link 05/2011 - 02/2008
3	COVID-19 VaccinesIBA 04/2022 - 11/2020
3	Immunoglobulin G (IgG)IBA 04/2022 - 01/2018
3	Combined VaccinesIBA 10/2020 - 01/2018
3	Biological ProductsIBA 01/2015 - 02/2006
3	HLA-B Antigens (HLA-B)IBA 11/2014 - 09/2011
3	HLA Antigens (Human Leukocyte Antigens)IBA 07/2012 - 03/2008
3	Chemokine ReceptorsIBA 09/2010 - 01/2002
3	Chemokine CCL5IBA 03/2008 - 09/2003
3	Pharmaceutical PreparationsIBA 09/2004 - 03/2002
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 09/2010
2	SARS-CoV-2 spike proteinIBA 03/2021 - 11/2020
2	Glycoproteins (Glycoprotein)IBA 07/2016 - 04/2016
2	env Gene ProductsIBA 01/2013 - 01/2012
2	Monoclonal AntibodiesIBA 07/2012 - 05/2010
2	LuciferasesIBA 01/2012 - 01/2009
2	beta-Galactosidase (Lactaid)IBA 01/2012 - 01/2009
2	CC ChemokinesIBA 05/2011 - 03/2008
2	Antiviral Agents (Antivirals)IBA 02/2008 - 08/2005
2	CCR ReceptorsIBA 09/2003 - 05/2003
2	HLA-DR Antigens (HLA-DR)IBA 04/2003 - 03/2002
1	aluminum sulfate (alum)IBA 05/2022
1	vesatolimodIBA 05/2022
1	Formaldehyde (Formol)FDA Link 01/2020
1	Respiratory Syncytial Virus VaccinesIBA 01/2020
1	SolutionsIBA 11/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018
1	AluminumIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Toll-Like Receptor 7IBA 12/2016
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 04/2016
1	NucleoproteinsIBA 04/2016
1	Ebola VaccinesIBA 04/2016
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2015
1	HLA-A Antigens (HLA-A)IBA 11/2014
1	Dihydrotachysterol (AT 10)IBA 10/2014
1	abacavir (Ziagen)FDA Link 07/2013
1	Lopinavir FDA Link 07/2013
1	Poliovirus VaccinesIBA 01/2013
1	Immunologic Factors (Immunomodulators)IBA 07/2012
1	NexusIBA 04/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Green Fluorescent ProteinsIBA 01/2012
1	Adenosine (Adenocard)FDA LinkGeneric 07/2011
1	NucleotidesIBA 05/2011
1	Peptides (Polypeptides)IBA 12/2010

Therapy/Procedure

10	Therapeutics 01/2020 - 04/2003
5	Highly Active Antiretroviral Therapy (HAART) 01/2012 - 03/2002
2	Aftercare (After-Treatment) 01/2020 - 08/2008
1	Bioreactors (Bioreactor) 10/2015
1	Art Therapy 10/2014